Arkolith/Insider Trading/DTIL/Form 4

Kelly John Alexander

Chief Financial OfficerPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$31K
Net Open-Market Flow
-$31K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)8K$3.84$31K126K
Feb 17, 2026Option exercise(M)28K—$0134K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Option exercise(M)28K—$055K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-009803) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML